An improved dual battery power system uses two separate battery power sources for an implantable cardioverter defibrillator, each having optimized characteristics for monitoring functions and for output energy delivery functions, respectively. The monitoring functions are supplied electrical power by a first battery source, such as a conventional pacemaker power source in the form of a lithium iodide battery which is optimized for long life at very low current levels. The output energy delivery functions are supplied by a separate second battery source, such as a pair of lithium vanadium pentoxide batteries, which is optimized for high current drain capability and low self-discharge for long shelf life. The first battery source provides electrical power only to the monitoring functions of the implantable cardioverter defibrillator, and the second battery source provides all of the electrical power for the output energy delivery functions.
|
0. 11. An implantable cardioverter defibrillator that is a self-contained human implantable device comprising:
monitoring means for detecting myocardial arrhythmias in a human patient;
output means for selectively determining an appropriate electrical pulse therapy to be delivered in response to a myocardial arrhythmia detected by the monitoring means and delivering the appropriate electrical pulse therapy to two or more implanted electrodes;
at least one battery means for providing electrical power to the output means; and
a voltage booster connected to at least one of said at least one battery means to insure a minimal booster voltage output of said at least one of said at least one battery means during periods of high current draw.
1. An improved power system for an implantable cardioverter defibrillator that is a self-contained human implantable device having comprising:
monitoring means for detecting myocardial arrhythmias in a human patient; and
output means for selectively determining an appropriate electrical pulse therapy to be delivered in response to a myocardial arrhythmia detected by the monitoring means and delivering the appropriate electrical pulse therapy to two or more implanted electrodes, the improved power system comprising: ;
first battery means for providing electrical power primarily to the monitoring means;
second battery means for providing substantially all of its electrical power to the output means; and
backup means for allowing the second battery means to provide electrical power to the monitoring means in the event that the first battery means can no longer provide electrical power to the monitoring means.
0. 15. An implantable cardioverter defibrillator that is a self-contained human implantable device comprising:
monitoring means for detecting myocardial arrhythmias in a human patient;
output means for selectively determining an appropriate electrical pulse therapy to be delivered in response to a myocardial arrhythmia detected by the monitoring means and delivering the appropriate electrical pulse therapy to two or more implanted electrodes;
at least one battery means connected to the output means;
an inverter circuit, including a high-voltage transformer, connected to the output means to provide a high voltage pulse to the output means; and
a voltage booster connected to at least one of said at least one battery, to insure a minimum boosted voltage output of said at least one of said at least one battery during periods of high current draw.
2. The improved power system implantable cardioverter defibrillator of
one or more cardioversion/defibrillation pulses, each cardioversion/defibrillation pulse being delivered by the output means as a capacitive discharge pulse from the capacitor means; and
one or more pacing pulses, each pulse being delivered by the output means as an electrical pulse directly powered from the second battery means.
3. The improved power system implantable cardioverter defibrillator of
transistor means operably connected to outputs of the first battery means and the second battery means to sense a current drain on the output of the first battery means and switch on the output of the second battery means to add to the output of the first battery means in the event that the current drain exceeds a maximum current drain of the first battery means.
4. The improved power system implantable cardioverter defibrillator of
voltage regulation means operably connected to an output of the first battery means and to a reference voltage value for regulating the output of the first battery means to a predetermined voltage value.
5. The improved power system implantable cardioverter defibrillator of
6. The improved power system implantable cardioverter defibrillator of
7. The improved power system implantable cardioverter defibrillator of
8. The improved power system implantable cardioverter defibrillator of
lithium silver vanadium oxides, thionyl chlorides or rechargeable battery cells.
0. 9. The implantable cardioverter defibrillator of
a voltage booster connected to said second battery means to insure a minimum boosted voltage to said output means during periods of high current draw.
0. 10. The implantable cardioverter defibrillator of
a voltage booster connected to said second battery means to prevent voltage ripple to said output means during periods of high current draw.
0. 12. The implantable cardioverter defibrillator of
a diode connected to said voltage booster to isolate the boosted voltage output from a voltage output of said at least one battery means.
0. 13. The implantable cardioverter defibrillator of
a charge pump circuit connected to the boosted voltage output to increase the boosted voltage output; and
an inverter circuit including a high voltage transformer connected to said charge pump circuit to produce a high voltage output from the increased boosted voltage output to charge the output means.
0. 14. The implantable cardioverter defibrillator of
a capacitor connected between said inverter circuit and said at least one battery means to decouple said at least one battery means from said inverter circuit.
0. 16. The implantable cardioverter defibrillator of
0. 17. The implantable cardioverter defibrillator of
0. 18. The implantable cardioverter defibrillator of
0. 19. The implantable cardioverter defibrillator of
at least one capacitor for storing a boosted voltage; and
a diode connected to said at least one capacitor to regulate said boosted voltage on said at least one capacitor, and to prevent said at least one capacitor from creating ripple in the voltage supplied to the output means.
0. 20. The implantable cardioverter defibrillator of
an activity monitor connected to said inverter circuit to time a charging operation of said at least one capacitor in accordance with activity by said inverter circuit.
|
operatea capacitor 146 . The 3.75 V output of the charge pump circuit 136 and the unregulated 6.0 Volt Bus are fed as inputs to a dual input voltage regulator 152. A voltage/current reference circuit 146 provides a reference voltage of 1.28 V and a reference current of 100 nA to the voltage regulator 152. A p-n-p transistor 154 controls whether the 6.0 Volt Bus input will be added to the 3.75 V output of the charge pump circuit 136 if a current overdraw condition exists with respect to the monitoring battery cell 111. The charge pump circuit 136 also provides a negative output of −2.0 to −2.5 V to supply the Main Power System negative voltage requirements of op amps, etc.
Referring now to
Referring now to
The voltage booster 130 of the preferred embodiment as shown in
Brumwell, Dennis A., Adams, Theodore P., Perttu, Joseph S., Supino, Charles G.
Patent | Priority | Assignee | Title |
7573154, | Jan 30 2007 | Perception Digital Limited | Battery operated portable electronic device having dual batteries |
8044536, | Oct 10 2007 | Boston Scientific Scimed, Inc | Powering devices having low and high voltage circuits |
8076903, | Jun 09 2009 | PALLADIUM ENERGY, INC | Electric power storage and delivery system and method of operation |
8676310, | Oct 31 2008 | Medtronic, Inc | Implantable medical device including two power sources |
9246382, | Aug 08 2013 | U S BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT | Charge pump including supply voltage-based control signal level |
Patent | Priority | Assignee | Title |
3783877, | |||
3865101, | |||
4031899, | Jan 22 1976 | VITATRON MEDICAL B V , A CORP OF THE NETHERLANDS | Long life cardiac pacer with switching power delivery means and method of alternately delivering power to respective circuit portions of a stimulus delivery system |
4134408, | Nov 12 1976 | PENNSYLVANIA RESEARCH CORPORATION, THE, | Cardiac pacer energy conservation system |
4197850, | Nov 03 1978 | PACESETTER, INC , A ST JUDE MEDICAL COMPANY | Implantable human tissue stimulator with memory protect means |
4237897, | Nov 03 1978 | Pacesetter, Inc | Battery life extender |
4323075, | Jul 02 1979 | MIROWSKI FAMILY VENTURES L L C | Battery failure compensation for a power supply used in an implantable defibrillator |
4345604, | Jan 22 1976 | VITATRON MEDICAL B V , A CORP OF THE NETHERLANDS | Long life cardiac pacer with switching power |
4416282, | Mar 02 1981 | Pacesetter, Inc | Cardiac pacer with improved, output circuitry |
4548209, | Feb 06 1984 | Medtronic, Inc. | Energy converter for implantable cardioverter |
4599523, | Feb 16 1984 | Intermedics, Inc. | Power priority system |
5342403, | Apr 09 1993 | Koninklijke Philips Electronics N V | Integrated defibrillator/monitor architecture with defibrillator-only fail-safe mode of operation |
5383907, | Dec 18 1992 | Angeion Corporation | System and method for delivering multiple closely spaced defibrillation pulses |
5389998, | Apr 08 1993 | Eastman Kodak Company | Camera power supply system |
5745350, | Jun 07 1996 | Pacesetter, Inc | Power supply circuit with a widely varying input voltage |
5757167, | Jul 12 1996 | Cardiac Pacemakers, Inc. | Voltage regulator |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Dec 13 1996 | Angeion Corp. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Oct 23 2006 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Oct 23 2006 | M1556: 11.5 yr surcharge- late pmt w/in 6 mo, Large Entity. |
Date | Maintenance Schedule |
Aug 16 2008 | 4 years fee payment window open |
Feb 16 2009 | 6 months grace period start (w surcharge) |
Aug 16 2009 | patent expiry (for year 4) |
Aug 16 2011 | 2 years to revive unintentionally abandoned end. (for year 4) |
Aug 16 2012 | 8 years fee payment window open |
Feb 16 2013 | 6 months grace period start (w surcharge) |
Aug 16 2013 | patent expiry (for year 8) |
Aug 16 2015 | 2 years to revive unintentionally abandoned end. (for year 8) |
Aug 16 2016 | 12 years fee payment window open |
Feb 16 2017 | 6 months grace period start (w surcharge) |
Aug 16 2017 | patent expiry (for year 12) |
Aug 16 2019 | 2 years to revive unintentionally abandoned end. (for year 12) |